Department of Chemistry, University of California, Berkeley, 826 Latimer Hall, Berkeley, California 94720, United States.
J Am Chem Soc. 2021 Feb 24;143(7):2970-2983. doi: 10.1021/jacs.0c13465. Epub 2021 Feb 11.
Structurally unprecedented antibacterial alkaloids containing multiple electron-rich pyrrole units have recently been isolated from sp. and fungi. This article documents the evolution of a synthetic program aimed at accessing the flagship metabolites curvulamine and curindolizine which are presumably a dimer and trimer of a CN biosynthetic building block, respectively. Starting with curvulamine, we detail several strategies to merge two simple, bioinspired fragments, which while ultimately unsuccessful, led us toward a pyrroloazepinone building block-based strategy and an improved synthesis of this 10π-aromatic heterocycle. A two-step annulation process was then designed to forge a conserved tetracyclic bis-pyrrole architecture and advanced into a variety of late-stage intermediates; unfortunately, however, a failed decarboxylation thwarted the total synthesis of curvulamine. By tailoring our annulation precursors, success was ultimately found through the use of a cyanohydrin nucleophile which enabled a 10-step total synthesis of curvulamine. Attempts were then made to realize a biomimetic coupling of curvulamine with an additional CN fragment to arrive at curindolizine, the most complex family member. Although unproductive, we developed a 14-step total synthesis of this alkaloid through an abiotic coupling approach. Throughout this work, effort was made to harness and exploit the innate reactivity of the pyrrole nucleus, an objective which has uncovered many interesting findings in the chemistry of this reactive heterocycle.
最近从 sp. 和 真菌中分离出了具有多个富电子吡咯单元的结构前所未有的抗菌生物碱。本文记录了一个合成计划的演变,该计划旨在获得标志性代谢产物卷曲胺和卷曲洛利嗪,它们分别是 CN 生物合成砌块的二聚体和三聚体。从卷曲胺开始,我们详细介绍了几种合并两个简单、受生物启发的片段的策略,尽管最终没有成功,但这些策略使我们走向了基于吡咯并氮杂酮砌块的策略,并改进了这种 10π-芳香杂环的合成。然后设计了两步环化过程来构建保守的四环双吡咯骨架,并进一步发展为各种晚期中间体;然而,不幸的是,脱羧反应失败导致卷曲胺的全合成失败。通过调整我们的环化前体,最终通过使用氰醇亲核试剂成功实现了卷曲胺的 10 步全合成。然后尝试通过生物模拟卷曲胺与额外的 CN 片段的偶联来实现卷曲洛利嗪,这是最复杂的家族成员。尽管没有成功,但我们通过非生物偶联方法开发了这种生物碱的 14 步全合成。在整个工作过程中,努力利用和利用吡咯核的固有反应性,这一目标在这个反应性杂环的化学中发现了许多有趣的发现。